MedicineBiology

Validation of polymerase chain reaction-indexed next-generation sequencing assay on the Illumina iSeq 100 platform for MPL exon 10 mutation detection: a robust alternative to Sanger sequencing.

D. Lau, Janice Yen Qi Loo, S. Ng, Dan Thu Van, Wei Cheng David Kuek, Chean Nee Chai, Joanna Kia Min Tan, Chun Kiat Lee, Benedict Yan, Tim Hon Man Chan

2026.6.1JOURNAL OF CLINICAL PATHOLOGY

DOI: 10.1136/jcp-2025-210226

Abstract

Abstract is not available.

Citation format

LAU, D., et al. Validation of polymerase chain reaction-indexed next-generation sequencing assay on the illumina iseq 100 platform for MPL exon 10 mutation detection: A robust alternative to sanger sequencing. JOURNAL OF CLINICAL PATHOLOGY, 2026: jcp-2025.